RAISE Act

United States117th CongressHR-2934House of Representatives
Updated: May 3, 2021

Summary

Renal Anemia Innovation Support and Expansion Act or the RAISE Act This bill allows coverage of prescription vitamin and mineral products under the Medicare prescription drug benefit if the products are administered orally and are used to treat iron deficiency anemia in individuals who have chronic kidney disease.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

S-4125: RAISE Act of 2022

Introduced in Senate

  1. Referred to the Subcommittee on Health.

    House of Representatives

  2. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    House of Representatives

  3. Introduced in House

  4. Referred to the Subcommittee on Health.

    House of Representatives